Drug Repurposing in COVID-19
The aim of this review is to describe regulatory and pharmacological aspects of drug repurposing and to identify drugs proposed for repurposing in COVID-19 based on the evidence to support their use in the treatment of this disease.The challenges of the correct interpretation of existing pre-clinical/clinical evidence as well as the generation of new evidence concerning drug repurposing in COVID-19 will also be discussed.
RECOMMENDED: [SOLVED] Drug Repurposing in COVID-19
With us, you are either satisfied 100% or you get your money back-No monkey business